This research examines whether metformin, a common diabetes drug, can improve social cognition in individuals with multiple sclerosis by promoting remyelination. Since MS damages nerve insulation, affecting brain function, the study explores whether treating co-occurring diabetes can reduce inflammation and symptoms, potentially leading to new regenerative therapies and improved quality of life.